Ceftaroline and ceftobiprole monotherapy for the treatment of Staphylococcus aureus infections: a systematic review and Bayesian meta-analysis. (PubMed, J Antimicrob Chemother) - Jul 15, 2026 - "Current evidence does not demonstrate superiority of ceftaroline or ceftobiprole over standard-of-care therapy for clinical cure in non-urinary S. aureus infections. Estimates remain imprecise and are largely driven by registrational trials and subgroup data. These findings support cautious, indication-specific interpretation rather than routine preference of these agents over established therapies."
Clinical • Journal • Monotherapy • Retrospective data • Review • Infectious Disease
|
|
Carlo Torti; Elena Matteini; Emanuele Rando; Eugenia Magrini; Federica Salvati; Flavio Sangiorgi; Francesca Catania; Jesús Rodríguez-Baño; Luis Eduardo López-Cortés; Marta Chiuchiarelli; Massimo Fantoni; Rita Murri
|